Arbutus Biopharma (ABUS) Asset Utilization Ratio (2014 - 2026)
Arbutus Biopharma's Asset Utilization Ratio came in at 0.66 for Q2 2026, up 371.1% from 0.14 a year earlier but down 36.0% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
For FY2025, Arbutus Biopharma's Asset Utilization Ratio was 0.12, up 178.4% from FY2024.
- Going back by year, Asset Utilization Ratio was 0.04 in FY2024 (-58.1%), 0.11 in FY2023 (-45.3%), 0.20 in FY2022 (+203.3%) and 0.06 in FY2021 (+12.9%).
- The five-year range for quarterly Asset Utilization Ratio is 0.04 (Q3 2024) to 1.03 (Q1 2026).
- Year-over-year, Asset Utilization Ratio increased in four of the last seven quarters, with growth averaging 109.1%.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q2 2026 (growth of 371.1%), and the weakest in Q3 2024 (a decline of 66.2%).
- Business Quant data shows ABUS's Asset Utilization Ratio at 1.03 (Q1 2026), 0.15 (Q4 2025) and 0.15 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 0.47 |
| 10 | Arbutus Biopharma | 960.50 Mn | 587.48 Mn | - | 0.66 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.66 |
| Mar 31, 2026 | 1.03 |
| Dec 31, 2025 | 0.15 |
| Sep 30, 2025 | 0.15 |
| Jun 30, 2025 | 0.14 |
| Mar 31, 2025 | 0.05 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.06 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | 0.12 |
| Sep 30, 2023 | 0.13 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 0.17 |
| Dec 31, 2022 | 0.20 |
| Sep 30, 2022 | 0.17 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.10 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.07 |
API Access
Arbutus Biopharma Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();